Responding, Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said: "Today's approval of palbociclib with fulvestrant for routine use...

23 September 2022

  Responding to research published in the BMJ about minimum tumour free margins in breast cancer surgery, Jane Murphy, Senior Clinical Nurse...

22 September 2022

  In response to new research published in the British Journal of Sports Medicine about physical activity and breast cancer risk, Dr Kotryna...

7 September 2022

Following internal NHS data seen by HSJ and BBC Newsnight revealing 'the number of patients waiting three months or longer...

11 August 2022

Following Dawn Butler MP appearance on This Morning, today, announcing her mission to find the Million Missing Mammograms, Breast Cancer Now said...

2 August 2022

Responding, Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said: “It’s absolutely fantastic news that following a provisional...

14 July 2022

Responding, Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said: “Today’s news that Trodelvy has finally been recommended by NICE...

14 July 2022

In response to the news abemaciclib has been approved by NICE for routine use on the NHS with hormone therapy following surgery for certain women...

17 June 2022

  In response to research published in Genome Medicine, and part funded by Breast Cancer Now, which suggests drugs that neutralise...

15 June 2022